1.Singapore consensus statements on the management of obstructive sleep apnoea.
Leong Chai LEOW ; Chuen Peng LEE ; Sridhar VENKATESWARAN ; Michael Teik Chung LIM ; Oon Hoe TEOH ; Ruth CHANG ; Yam Cheng CHEE ; Khai Beng CHONG ; Ai Ping CHUA ; Joshua GOOLEY ; Hong Juan HAN ; Nur Izzianie KAMARUDDIN ; See Meng KHOO ; Lynn Huiting KOH ; Shaun Ray Han LOH ; Kok Weng LYE ; Mark IGNATIUS ; Yingjuan MOK ; Jing Hao NG ; Thun How ONG ; Chu Qin PHUA ; Rui Ya SOH ; Pei Rong SONG ; Adeline TAN ; Alvin TAN ; Terry TAN ; Jenny TANG ; David TAY ; Jade TAY ; Song Tar TOH ; Serene WONG ; Chiang Yin WONG ; Mimi YOW
Annals of the Academy of Medicine, Singapore 2025;54(10):627-643
INTRODUCTION:
Obstructive sleep apnoea (OSA) is common in Singapore, with moderate to severe OSA affecting around 30% of residents. These consensus statements aim to provide scientifically grounded recommendations for the management of OSA, standar-dise the management of OSA in Singapore and promote multidisciplinary collaboration.
METHOD:
An expert panel, which was convened in 2024, identified several areas of OSA management that require guidance. The expert panel reviewed the current literature and developed consensus statements, which were later independently voted on using a 3-point Likert scale (agree, neutral or disagree). Consensus (total ratings of agree and neutral) was set a priori at ≥80% agreement. Any statement not reaching consensus was excluded.
RESULTS:
The final consensus included 49 statements that provide guidance on the screening, diagnosis and management of adults with OSA. Additionally, 23 statements on the screening, diagnosis and management of paediatric OSA achieved consensus. These 72 consensus statements considered not only the latest clinical evidence but also the benefits and harms, resource implications, feasibility, acceptability and equity impact of the recommendations.
CONCLUSION
The statements presented in this paper aim to guide clinicians based on the most updated evidence and collective expert opinion from sleep specialists in Singapore. These recommendations should augment clinical judgement rather than replace it. Management decisions should be individualised, taking into account the patient's clinical characteristics, as well as patient and caregiver concerns and preferences.
Humans
;
Sleep Apnea, Obstructive/diagnosis*
;
Singapore
;
Consensus
;
Adult
2.C2 En Bloc Hemilaminectomy and Recapping Using Laminar Screws: A New Approach to Preserve the C2 Extensor Muscles during Intradural Tumor Resection at the C2 Level: A Technical Report.
Gun Woo LEE ; Sung Shik KANG ; Mary Ruth Alfonso PADUA ; Ho Joong KIM ; Bong Soon CHANG ; Choon Ki LEE ; Jin S YEOM
The Journal of the Korean Orthopaedic Association 2012;47(6):452-456
Conventional posterior approach for resection of an intradural tumor at C2 involves C2 lamincectomy and detachment of extensor muscles from C2 spinous process. Being major extensors of the cervical spine, the destruction of C2-attached muscles may lead to detrimental consequences, namely, neck pain, limited neck motion, progressive kyphosis, and instability. We report a new technique on exposing and reconstructing the C2 level while preserving C2 extensors for resection of an intradural tumor at C2 level. We performed an en bloc hemilaminectomy of C2 while carefully preserving C2 extensor muscles to adequately expose the dura mater at the C2 level. After removal of the tumor, we proceeded with the reconstruction by recapping the C2 hemilamina using 2 laminar screws.
Dura Mater
;
Kyphosis
;
Muscles
;
Neck
;
Neck Pain
;
Spine
3.Brain Metastasis and Leptomeningeal Carcinomatosis in Breast Cancer.
Yoon Soo CHANG ; Jeong Hun SEO ; Ruth LEE ; Joong Bae AHN ; Kwang Yong SHIM ; Soo Jung GONG ; Hwa Young LEE ; Sun Young RHA ; Nae Choon YOO ; Chang Ok SUH ; Joo Hang KIM ; Jae Kyung RHO ; Kyong Sik LEE ; Jin Sik MIN ; Byung Soo KIM ; Hyun Cheol CHUNG
Journal of the Korean Cancer Association 1998;30(3):464-474
PURPOSE: Brain metastasis is estimated to occur in 20 to 40% of cancer patients, and meningeal involvement has been reported in 5% to 8% of cancer patients. Even if the prognosis is grave, standard treatment modality of brain metastasis or leptomeningeal carcinomatosis has not been established. We evaluated the prognosis and the clinical features of the brain and leptomeningeal metastasis of the breast cancer. MATERIALS AND METHODS: The 43 patients who was diagnosed as brain parenchymal metastasis or leptomeningeal carcinomatosis clinically, radiologically and/or cytologically were included in this study. The median age was 44(range: 27-61) years. RESULTS: The median duration from brain metastasis to death was 181 days(range: 8~1599), and the median duration from leptomeningeal carcinomatosis to death was 39 days(range: 25~152). Age(p=0.7174) and number of brain metastatic lesion(p=0.4097) did not influence the survival, but the presence of other systemic metastatic lesion affected the survival(p 0.0224). When we compared the survival rates of patients according to treatment modality, the patients with systemic chemotherapy versus patients without systemic chemotherapy showed differences(p= 0.0009). Patients treated with whole brain radiation only versus patients with whole brain radiation and other systemic management also showed different survival rate(p=0.0009). But intrathecal chemotherapy had no effect on survival. Well differentiated, solitary lesions were treated by operation and/or gamma-knife surgery, and their effects were good. CONCLUSION: Prolongation of survival was suggested with whole brain radiotherapy combined with systemic treatment in brain or leptomeningeal metastasis. Further study is expected to confirm this finding.
Brain*
;
Breast Neoplasms*
;
Breast*
;
Drug Therapy
;
Humans
;
Meningeal Carcinomatosis*
;
Neoplasm Metastasis*
;
Prognosis
;
Radiotherapy
;
Survival Rate

Result Analysis
Print
Save
E-mail